THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Life Sciences: Biotech

New front developing in war on killer bugs

Drug tested against toughest bacteria

By Diedtra Henderson
Globe Staff / March 27, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

(Correction: Because of a reporting error, a story in yesterday's Business & Innovation section incorrectly characterized estimates associated with a new drug to combat Staphylococcus aureus in the bloodstream. Cubist Pharmaceuticals estimates the US market for treatments of the disease to be $1 billion.) (Full article: 1214 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass